BMRA - バイオメリカ （Biomerica Inc.）

Biomerica continues to advance on its pipeline, building momentum around its IBS product and H.Pylori diagnostic test. See more on BMRA stock here.

Expands Commercialization Efforts in Areas with High Unmet Needs Expands Commercialization Efforts in Areas with High Unmet Needs

The new research study that is being offered here is an excellent compilation of numerous analyses of important elements of the Global Human Chorionic Gonadotropin Test Kit Market. It clarifies how the Human Chorionic Gonadotropin Test Kit market is anticipated

Although Biomerica announced encouraging product integration news, BMRA stock ultimately fell on broader market weakness.

Simple at-home device to increase sensitivity in breast self-exams Early detection of breast cancer saves lives About 80% of breast cancer is detected by women themselves who notice changes in their breast IRVINE, Calif., Oct. 14, 2022 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced that under a General Merchandise Supplier Agreement

Biomerica Inc. (NASDAQ:BMRA)’s traded shares stood at 0.1 million during the last session, with the company’s beta value hitting -0.34. At the close of trading, the stock’s price was $2.77, to imply an increase of 4.92% or $0.13 in intraday trading. The BMRA share’s 52-week high remains $7.38, putting it -166.43% down since that peak … What Could Change After Biomerica Inc. (NASDAQ: BMRA) Gains 7.58% From The High-Point? Read More »

Biomerica Inc (NASDAQ: BMRA ) announced that its Aware Breast Self Exam device will now be sold in Walmart Inc''s (NYSE: WMT ) retail system. The Biomerica FDA-cleared Aware Breast Self Exam device is a way for women to enhance tactile sensitivity to changes or irregularities in breast tissue, … Full story available on Benzinga.com

U.S. stocks traded lower this morning, following the release of economic reports on initial jobless claims and producer prices Following the market opening Thursday, the Dow traded down 1.92% to 30,182.23 while the NASDAQ fell 2.01% to 11,021.66. The S&P also fell, dropping, 2% to 3,725.83. Also check this: Markets In Extreme Fear With Rising Inflation Rates Leading and Lagging Sectors Consumer staples shares fell by just 1.1% on Thursday. Meanwhile, top gainers in the sector included Yatsen Holding Limited (NYSE: YSG ), up 14% and Bridgford Foods Corporation (NASDAQ: BRID ) up 8%. In trading on Thursday, energy shares dipped by 4.3%. Top Headline Producer prices for final demand rose 1.1% month-over-month in June, the mosy in three months and also above analysts’ expectations of 0.8%. Equities Trading UP SaverOne 2014 Ltd (NASDAQ: SVRE ) shares shot up 37% to $3.9501. SaverOne 2014 recently named Israel Eybi as Chief Marketing and Sales Officer. Shares of Biomerica, Inc. (NASDAQ: BMRA ) got a boost, shooting 25% to $3.71 following news the company''s breast self exam will …

Biomerica (BMRA) stock surged ~28% in Thursday premarket trading after the company said its Aware Breast Self Exam device will now be sold by Walmart (WMT).BMRA said that Walmart…

Simple at-home device to increase sensitivity in breast self exams Early detection of breast cancer saves lives Breast Cancer accounts for 1 in 3 new cases of cancer in women annually IRVINE, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced that under a General Merchandise Supplier Agreement with Walmart, the Company’s

IRVINE, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA ) today announced that the Canadian Patent Office has issued a notice of allowance for Biomericas patent application pertaining to the Companys InFoods® diagnostic guided therapy platform technology that offers a novel approach in the treatment of patients suffering from Irritable Bowel Syndrome (IBS). IBS is a chronic, often debilitating, functional gastrointestinal (GI) disorder with symptoms that include abdominal pain, bloating, and altered bowel behaviors, such as constipation and/or diarrhea, or alternating between the two.

Biomerica, Inc. (NASDAQ:BMRA) saw a significant increase in short interest in the month of October. As of October 15th, there was short interest totalling 1,320,000 shares, an increase of 66.2% from the September 30th total of 794,300 shares. Based on an average daily volume of 2,020,000 shares, the short-interest ratio is presently 0.7 days. Currently, []

IRVINE, Calif. , Oct. 29, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced that in conjunction with Breast Cancer Awareness month, which takes place each October, it has launched its new website for the Aware ® at-home breast self-exam pad. Breast cancer is the most commonly-diagnosed cancer in women. In 2021, an estimated 281,550 new cases of invasive breast cancer will be diagnosed and approximately 43,600 women will die from breast cancer in US. One in eight women will develop invasive breast cancer in their lifetime.

The “Helicobacter Pylori Rapid Test Kit Market” report describes in detail the demand and consumption of various products/services related to the market growth dynamics during the forecast period of 2021-2027. A detailed market assessment of the various opportunities in the